RESUMEN
Vitamin A reduces measles morbidity/mortality and and is recommended for management. We studied 142 patients hospitalized at US Children's hospitals for measles between January 1, 2004, and March 31, 2019, and found only 47 (33%) received vitamin A. Patients with complex chronic conditions were less likely to be treated. This study highlights a concerning gap between recommendations and practice for hospital management of measles.
Asunto(s)
Hospitalización/estadística & datos numéricos , Sarampión/prevención & control , Sarampión/fisiopatología , Vitamina A/administración & dosificación , Adolescente , Niño , Preescolar , Hospitales Pediátricos/estadística & datos numéricos , Humanos , Lactante , Recién Nacido , Sarampión/complicaciones , Morbilidad , Estudios Retrospectivos , Estados Unidos , Vitamina A/uso terapéuticoRESUMEN
Our objective was to retrospectively describe measles hospitalizations in 52 US children's hospitals. We identified 136 patients hospitalized for measles in 2004-2018; 17% (23/136) had complex chronic conditions, 2 of whom died or were in hospice. Among noncomplex patients only 39% received vitamin A, median length of stay was 3 days and median adjusted estimated costs were $5896.